Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BICALUTAMIDE Cause Disease recurrence? 17 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Disease recurrence have been filed in association with BICALUTAMIDE (Bicalutamide). This represents 0.4% of all adverse event reports for BICALUTAMIDE.

17
Reports of Disease recurrence with BICALUTAMIDE
0.4%
of all BICALUTAMIDE reports
2
Deaths
1
Hospitalizations

How Dangerous Is Disease recurrence From BICALUTAMIDE?

Of the 17 reports, 2 (11.8%) resulted in death, 1 (5.9%) required hospitalization, and 4 (23.5%) were considered life-threatening.

Is Disease recurrence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BICALUTAMIDE. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does BICALUTAMIDE Cause?

Malignant neoplasm progression (352) Prostatic specific antigen increased (322) Drug ineffective (268) Fatigue (258) Prostate cancer (258) Asthenia (223) Hot flush (219) Off label use (171) Disease progression (169) Anaemia (164)

What Other Drugs Cause Disease recurrence?

NIRMATRELVIR\RITONAVIR (20,040) PREDNISONE (1,979) CYCLOPHOSPHAMIDE (1,689) RITUXIMAB (1,588) METHOTREXATE (1,401) DOXORUBICIN (980) VINCRISTINE (932) PREDNISOLONE (873) MYCOPHENOLATE MOFETIL (852) DEXAMETHASONE (784)

Which BICALUTAMIDE Alternatives Have Lower Disease recurrence Risk?

BICALUTAMIDE vs BICTEGRAVIR BICALUTAMIDE vs BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS BICALUTAMIDE vs BILASTINE

Related Pages

BICALUTAMIDE Full Profile All Disease recurrence Reports All Drugs Causing Disease recurrence BICALUTAMIDE Demographics